Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials
Parker AB, Naylor CD. Am Heart J. 2000; 139(6):952-61.
Parker AB, Naylor CD. Am Heart J. 2000; 139(6):952-61.
Hill MD, Silver FL, Austin PC, Tu JV. Stroke. 2000; 31(1):123-7.
Rochon PA, Anderson GM, Tu JV, Clark JP, Gurwitz JH, Szalai JP, Lau P. CMAJ. 1999; 161(11):1403-8.
Tu JV, Naylor CD, Austin P. CMAJ. 1999; 161(10):1257-61.
Alter DA, Naylor CD, Austin P, Tu JV. N Engl J Med. 1999; 341(18):1359-67.
Mariotto A, De Leo D, Buono MD, Favaretti C, Austin P, Naylor CD. Lancet. 1999; 354(9177):467-70.
Cohen EA, Young W, Slaughter PM, Oh P, Naylor CD. Am Heart J. 1999; 137(6):1012-8.
Ivanov J, Tu JV, Naylor CD. Circulation. 1999; 99(16):2098-104.
Llewellyn-Thomas H, Thiel E, Paterson J, Naylor D. J Health Serv Res Policy. 1999; 4(2):65-72.
Kucey DS, Bowyer B, Iron K, Austin P, Anderson G, Tu JV. J Vasc Surg. 1998; 28(6):1051-8.